Dr. Reddy's Laboratories
Hyderabad, Telangana, India · Biotechnology, Employee Benefits, Health Care
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, India, specializing in the development, manufacturing, and marketing of a wide range of pharmaceuticals.
Key facts
- Headquarters
- Hyderabad, Telangana, India
- Employees
- 28,000
- Industries
- Biotechnology, Employee Benefits, Health Care
- Website
- www.drreddys.in
- Company page
Recent activity at Dr. Reddy's Laboratories
- : Dr Reddy’s Laboratories partners with Takeda Biopharmaceuticals for exclusive distribution of Qdenga vaccine in India.
- : Dr. Reddy's Laboratories Appoints Sanjay Sharma as Chief Human Resources Officer
- : Dr. Reddy's Laboratories launches Ivermectin Tablets USP, 3 mg, in the U.S. market.
- : Dr. Reddy's Laboratories Appoints Milan Kalawadia as Chief Executive Officer (North America)
Leadership
- Sanjay Sharma, Chief Human Resources Officer
- Milan Kalawadia, Chief Executive Officer
Verified email and direct lines for Dr. Reddy's Laboratories’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Dr. Reddy's Laboratories in the news
- Dr. Reddy’s gets marketing authorisation for generic semaglutide injection in Brazil - BusinessLine (Nov 05, 2026)
- FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483 - Fierce Pharma (Jun 26, 2026)
- India's Dr Reddy's says semaglutide shipping disruption to last until at least late October - Reuters (Jul 09, 2026)
- Dr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi & Korsinsky - PR Newswire (Jul 31, 2026)
- Dr Reddy’s injectable lenacapavir for HIV prevention gets tentative nod from USFDA - BusinessLine (Nov 02, 2026)
- Dr Reddy's Laboratories stock in focus as USFDA completes pre-approval inspection at FTO-9 plant - Business Today (Oct 15, 2026)
- Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States - Business Wire (Aug 04, 2026)
- Explained — Why Dr. Reddy's Laboratories shares are down in a strong market - CNBC TV18 (Apr 15, 2026)
Companies similar to Dr. Reddy's Laboratories
- Cipla · Biotechnology, Health Care, Manufacturing, Pharmaceutical, pharmaceuticals
- Teva Pharmaceutical Industries Ltd · Biotechnology, Health Care, Manufacturing, Pharmaceutical
- Bristol Myers Squibb · Biotechnology, Health Care, Manufacturing, Pharmaceutical
- Mylan · Biotechnology, Health Care, Manufacturing, Pharmaceutical
- Glenmark Pharmaceuticals · Biotechnology, Manufacturing, Pharmaceutical, pharmaceuticals
About Dr. Reddy's Laboratories: questions and answers
What does Dr. Reddy's Laboratories do?
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, India, specializing in the development, manufacturing, and marketing of a wide range of pharmaceuticals.
Where is Dr. Reddy's Laboratories headquartered?
Dr. Reddy's Laboratories is headquartered in Hyderabad, Telangana, India.
How many employees does Dr. Reddy's Laboratories have?
Dr. Reddy's Laboratories has about 28,000 employees.
Who leads Dr. Reddy's Laboratories?
Milan Kalawadia is a Chief Executive Officer at Dr. Reddy's Laboratories.
What is the latest news on Dr. Reddy's Laboratories?
On Sep 18, 2026, Dr Reddy’s Laboratories partners with Takeda Biopharmaceuticals for exclusive distribution of Qdenga vaccine in India.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy